Moirangthem Meenakumari Devi | Mathematics | Best Researcher Award

Posted on by Shen Awards

Ms. Moirangthem Meenakumari Devi | Mathematics | Best Researcher Award

Manipur University, India 

Moirangthem Meenakumari Devi is an emerging research scholar in the field of relativity and cosmology, currently pursuing her doctoral studies at Manipur University, Imphal. With a strong academic background in Mathematics from top-tier institutions such as the University of Delhi and Miranda House, she has consistently demonstrated intellectual rigor and a passion for theoretical sciences. She is a highly motivated individual with strong organizational skills and a keen interest in exploring and investigating new ideas through scientific inquiry. Her career aspirations align with contributing meaningfully to the scientific community by solving complex problems and advancing the frontiers of knowledge in mathematical physics. In addition to her academic pursuits, she possesses strong problem-solving and critical thinking abilities, which are essential for success in high-level research. Her enthusiasm for learning and her commitment to excellence position her as a capable and dedicated scholar with the potential to make a significant impact in her domain. Though early in her research career, her academic journey and proactive mindset reflect a deep-rooted commitment to the advancement of science and a future filled with scholarly promise.

Professional Profile

Education

Moirangthem Meenakumari Devi’s academic background is grounded in a strong foundation of mathematics, cultivated through rigorous study at some of India’s most respected educational institutions. She is currently enrolled in a Ph.D. program at Manipur University, Imphal, focusing her research in the advanced field of relativity and cosmology. Prior to this, she completed her Master of Science (M.Sc.) in Mathematics from the Faculty of Mathematical Sciences, University of Delhi, from June 2019 to June 2021, graduating with a CGPA of 8.31. Her undergraduate studies were completed at Miranda House, University of Delhi, where she earned a B.Sc. (Hons) in Mathematics between June 2016 and June 2019, scoring a CGPA of 8.23. Her foundational years were spent at Xtra Edge School in Imphal, where she completed her Higher Secondary education with an impressive 85.04% from June 2014 to June 2016. This strong educational trajectory underscores her dedication to academic excellence and her preparedness to engage in deep and sustained scientific inquiry. Each stage of her education has contributed to refining her analytical capabilities and theoretical understanding, equipping her for high-level research in cosmology and mathematical physics.

Professional Experience

As a young and passionate scholar, Moirangthem Meenakumari Devi is currently engaged full-time in her Ph.D. research at Manipur University, beginning in May 2022. While she may not yet have held conventional professional roles in academia or industry, her current position as a research scholar involves extensive academic responsibility, including conducting literature reviews, performing theoretical modeling, analyzing data, and developing new insights in the field of relativity and cosmology. Her role as a doctoral researcher also includes collaborating with faculty members, participating in academic discussions, and contributing to the university’s research output. Through this experience, she has been refining critical skills such as independent research, scientific writing, time management, and academic presentation. Her pursuit of knowledge within a highly specialized domain demonstrates professional maturity and a readiness to grow into future roles within academia or research institutions. While formal job experience is limited due to her continued focus on education and research, the depth and rigor of her doctoral work reflect the professional discipline, intellectual curiosity, and commitment essential for a successful research career.

Research Interest

Moirangthem Meenakumari Devi’s core research interest lies in the realm of relativity and cosmology, areas that explore the nature of spacetime, the universe’s structure, and the fundamental forces that govern cosmic phenomena. Her current doctoral work delves into theoretical aspects of general relativity, gravitational models, and cosmological theories, aiming to address key questions in the evolution and dynamics of the universe. Her mathematical background supports the analytical complexity required for such research, including differential equations, tensor calculus, and mathematical modeling of physical systems. She is particularly drawn to the intersection of mathematics and physics, where abstract theory can yield concrete understanding of the universe’s origin, structure, and eventual fate. This focus not only contributes to fundamental science but also opens avenues for applied research in astrophysics and theoretical physics. By integrating rigorous mathematics with deep physical concepts, her research aims to expand scientific knowledge and inspire further exploration into the mysteries of the cosmos. Her growing expertise in cosmology positions her to contribute meaningfully to the academic community and to future scientific advancements in this critical area of physics.

Research Skills

Moirangthem Meenakumari Devi possesses a strong suite of research skills that are well-aligned with the demands of theoretical and mathematical physics. Her key competencies include advanced problem-solving and critical thinking, both of which are essential for formulating and testing hypotheses in complex domains like relativity and cosmology. She demonstrates proficiency in mathematical reasoning, logical deduction, and the ability to work through abstract theoretical problems with precision and patience. Her graduate and doctoral studies have equipped her with skills in analytical computation, theoretical modeling, and scientific reasoning. Additionally, she is developing her skills in academic writing, enabling her to communicate complex ideas clearly and effectively through reports, research papers, and presentations. She is also proficient in English and Hindi, which aids in academic collaboration and dissemination of knowledge across diverse platforms. Her adaptability and eagerness to learn are reflected in her interest in exploring new mathematical frameworks and methodologies. As she continues her research, she is likely to deepen her experience with scientific tools, programming for simulations, and collaborative research techniques that will enhance her academic and professional impact.

Awards and Honors

As of now, Moirangthem Meenakumari Devi’s profile does not list any specific awards or honors. However, her consistent academic excellence, demonstrated through high CGPAs in both undergraduate and postgraduate studies from institutions like Miranda House and the University of Delhi, suggests a strong performance track record. These accomplishments are often competitive and reflect distinction among peers, especially in rigorous subjects such as mathematics. Additionally, gaining admission into a Ph.D. program in a specialized and demanding field like relativity and cosmology is itself a significant academic milestone. With ongoing research and potential future publications, conference presentations, or fellowships, she is well-positioned to earn formal recognitions and awards in the coming stages of her academic career. Active participation in scholarly activities, submission to journals, and engagement in research communities will further enhance her profile for national and international honors. As she progresses, awards acknowledging young researchers or contributions to fundamental science will likely follow, adding to her credibility and standing in the academic world.

Conclusion

Moirangthem Meenakumari Devi embodies the qualities of a focused, intelligent, and driven research scholar poised for a successful academic career in theoretical physics. Her journey from an outstanding mathematics student to a Ph.D. researcher in relativity and cosmology is a testament to her dedication, intellectual curiosity, and resilience. Although at an early stage in her research career, her academic background, sharp analytical abilities, and passion for fundamental science provide a strong foundation for future contributions. With continued effort, engagement in scholarly activities, and active dissemination of her research, she is expected to emerge as a significant contributor in the field. The depth of her research interest, coupled with her evolving research skills, makes her a promising candidate for academic and research recognitions in the future. She is well-suited for opportunities that support early-career researchers and can be confidently recommended for awards, fellowships, and collaborative projects that encourage academic excellence and scientific advancement.

Publications Top Notes

  1. Parametrization of the Hubble parameter in f(R,T) theory
    Authors: Moirangthem Meenakumari Devi, Kangujam Priyokumar Singh
    Year: 2025
    Published in: International Journal of Modern Physics A
  2. Exploring the limitless potential of the hyperbolic scale factor in a spherically symmetric spacetime
    Authors: Moirangthem Meenakumari Devi, Kangujam Priyokumar Singh
    Year: 2025
    Published in: Modern Physics Letters A

Doug Chung | Biological Sciences | Best Researcher Award

Posted on by Shen Awards

Prof. Dr. Doug Chung | Biological Sciences | Best Researcher Award

Chungnam National University, South Korea

Dr. Doug Young Chung is a distinguished soil scientist with an accomplished academic and research career spanning over three decades. Dr. Chung has dedicated his professional life to advancing the field of soil science through education, research, and leadership. He has served as a Professor at Chungnam National University from October 1995 to August 2022, where he contributed significantly to both academic instruction and scientific innovation. His expertise lies primarily in soil physics and soil biophysics, with a research focus on soil management, erosion control, nutrient distribution, and sustainable agricultural practices. Dr. Chung has a robust publication record in reputable journals, particularly the Korean Journal of Agricultural Science, and is also the author of key textbooks on soil science and environmental sustainability. His leadership roles in professional societies and editorial positions further highlight his dedication to scientific excellence and community service. Dr. Chung’s comprehensive academic background, practical research outcomes, and strong mentorship contributions underscore his qualification as a leading researcher in his field. His work has had lasting impact on agricultural science in Korea and continues to inform sustainable land-use practices in coastal and reclaimed areas.

Professional Profile

Education

Dr. Doug Young Chung’s educational foundation is grounded in rigorous training in agronomy and soil science, obtained from prestigious institutions in both Korea and the United States. He began his academic journey with a Bachelor of Science degree in Agronomy from Konkuk University, Korea, completed in February 1983. His growing interest in the physical and biological properties of soil systems led him to pursue graduate studies abroad. He earned a Master of Science degree in Soil Science with a specialization in Soil Biophysics from Michigan State University in May 1987. This training enabled him to develop a deeper understanding of the interactions between soil physical properties and biological activity, particularly in relation to water retention and soil structure. In December 1993, he obtained his Ph.D. in Soil Science from Clemson University, specializing in Soil Physics. His doctoral work laid a critical foundation for his future research in soil erosion, salinity management, and nutrient dynamics in various agricultural landscapes. These academic achievements have provided Dr. Chung with a broad and interdisciplinary framework to address complex challenges in soil science and sustainable agriculture, and they continue to influence his scientific and pedagogical approach in professional practice.

Professional Experience

Dr. Doug Young Chung has an extensive and impactful professional career characterized by both academic excellence and industry collaboration. He began his research career as a Research Associate at the Korea Institute of Science and Technology (KIST) in 1994, followed by a similar position at Jinro Research Institute until 1995. His academic tenure commenced in October 1995 when he joined Chungnam National University as a professor in the Institute of Agricultural Science. Over the next 27 years, he played a vital role in educating undergraduate and graduate students while conducting pioneering research in soil science. His areas of instruction and mentorship spanned soil biophysics, environmental sustainability, and land reclamation. Between 2002 and 2004, he served as Editor-in-Chief of the Korean Journal of Soil Science and Fertilizer, demonstrating his leadership and editorial expertise. Furthermore, from 2003 to 2012, Dr. Chung served as Vice President of the Korean Society of Soil Science and Fertilizer, where he facilitated scientific dialogue and policy engagement. His dual experience in academia and industry has given him a balanced perspective on the practical applications of soil research, enabling him to influence agricultural practices, environmental management, and policy development in Korea and beyond.

Research Interest

Dr. Doug Young Chung’s research interests are centered around soil physics and biophysics, with a particular emphasis on sustainable land management and soil quality improvement. His work explores the physical behavior of soil under various environmental conditions, especially in the context of erosion control, nutrient cycling, and water retention. A significant part of his research has been devoted to understanding the dynamics of reclaimed tidal lands in Korea, such as the Saemangeum region, where he has investigated salinity management and organic matter enhancement through strategic crop cultivation. Dr. Chung is also interested in the application of models such as the van Genuchten equation for predicting soil water retention, with a focus on particle size effects, including materials like perlite. His research also addresses spatial variability of nutrients in different land-use systems, particularly at the interface of forest and agricultural lands. Furthermore, he examines how soil properties influence ecological functions and agricultural productivity, offering practical solutions to improve soil health. His interest in integrating traditional soil science with environmental monitoring and agricultural sustainability has made his work both regionally relevant and globally resonant, especially in light of climate change and food security challenges.

Research Skills

Dr. Doug Young Chung possesses a well-rounded set of research skills that span fieldwork, laboratory analysis, computational modeling, and scientific writing. His expertise in soil physics equips him with the ability to analyze complex soil-water-plant interactions, critical for understanding erosion, salinity, and organic matter dynamics. He is skilled in applying models such as the van Genuchten retention curve to evaluate water holding capacity in soils with different textural properties, including reclaimed and marginal lands. His field-based research involves soil sampling, texture classification, and environmental monitoring, which are essential for assessing soil fertility and degradation. In the laboratory, he is proficient in techniques related to soil moisture analysis, nutrient profiling, and structural stability. Moreover, Dr. Chung has strong capabilities in data interpretation and technical writing, evidenced by his numerous peer-reviewed journal articles and textbooks. His editorial leadership further highlights his meticulous attention to scientific clarity and accuracy. Additionally, his ability to design and implement long-term field trials showcases his project management and interdisciplinary collaboration skills. Collectively, these competencies enable Dr. Chung to conduct high-quality research that contributes meaningfully to soil science and agricultural sustainability.

Awards and Honors

While specific awards and honors are not detailed in the provided resume, Dr. Doug Young Chung’s appointments and leadership roles in academic societies speak volumes about the recognition he has received within the scientific community. His tenure as Editor-in-Chief of the Korean Journal of Soil Science and Fertilizer from 2002 to 2004 reflects the trust placed in him to uphold the standards of one of Korea’s most important agricultural journals. Additionally, his long-standing service as Vice President of the Korean Society of Soil Science and Fertilizer from 2003 to 2012 is indicative of his respected status among peers and his significant contributions to advancing soil science in Korea. His authorship of two key academic books, including Soil Science (2006) and Soils and Life (2014), suggests further recognition of his thought leadership in the field. Though no formal honors are listed, these achievements imply a high degree of peer esteem, academic influence, and national-level impact. Future documentation of international recognitions, conference awards, or citation metrics could further highlight his contributions and broaden his profile in global academic networks.

Conclusion

Dr. Doug Young Chung represents a model of academic excellence and dedication in the field of soil science. With over 30 years of professional experience, his contributions to education, research, and professional service are extensive and impactful. His scientific investigations into soil physical properties, erosion management, water retention, and nutrient dynamics have directly influenced agricultural practices and environmental management strategies in Korea, especially in challenging areas like reclaimed tidal lands. Through his roles in academic publishing and society leadership, Dr. Chung has helped shape the direction of soil science research and policy in his country. While further international collaboration and global recognition would enhance the reach of his work, his foundational research and educational impact are undeniable. His textbooks serve as important resources for students and practitioners alike, reflecting his commitment to knowledge dissemination. In summary, Dr. Chung’s career reflects a lifetime of contribution to soil science, making him a highly suitable candidate for recognition such as the Best Researcher Award. His work not only advances academic understanding but also contributes to solving real-world problems in agriculture and environmental sustainability.

Publications Top Notes

  1. Simple assessment of wind erosion depending on the soil texture and threshold wind velocity in reclaimed tidal flat land
    Authors: Chung et al.
    Year: 2016
    Journal: Korean Journal of Agricultural Science
  2. Estimation of Water Retention Characteristics Depending on the Particle Sizes of Perlite Using van Genuchten Equation with Retention Curve Program
    Authors: Chung et al.
    Year: 2021
    Journal: Korean Journal of Agricultural Science
  3. Distribution of Nitrogen and Phosphorus in Arable and Forest Stand along the Boundary of Upstream Daechung Reservoir
    Authors: Chung et al.
    Year: 2018
    Journal: Korean Journal of Agricultural Science
  4. Managing Soil Organic Matter and Salinity by Crop Cultivation in Saemangeum Reclaimed Tidal Land
    Authors: Chung et al.
    Year: 2020
    Journal: Korean Journal of Agricultural Science

Valentina Giai | Ematologia | Women Researcher Award

Posted on by Shen Awards

Dr. Valentina Giai | Ematologia | Women Researcher Award

Città della Salute e della Scienza, Torino, Italy

Dr. Valentina Giai is a distinguished hematologist and researcher with over two decades of experience in academic medicine and clinical hematology. She completed her MD and hematology training at the University of Torino, Italy, where she later earned her PhD in Experimental Medicine. Her postdoctoral work includes significant contributions at the Karolinska Institutet in Sweden, focusing on regenerative medicine and hematopoietic stem cells. Dr. Giai has held key clinical positions across major Italian hospitals, currently serving at Città della Salute e della Scienza in Torino. Her research spans chronic myeloid leukemia, myelodysplastic syndromes, and acute myeloid leukemia, contributing to pivotal clinical trials and real-world studies. A prolific author, she has co-authored numerous high-impact publications and participated in international collaborations. Her career reflects a seamless blend of patient care, clinical innovation, and research excellence, with a commitment to improving hematologic therapies and outcomes.

Professional Profile

Scopus

Orcid

🎓 Education 

Dr. Giai’s academic foundation began at the Liceo Scientifico Marie Curie in Pinerolo (1994–1999), followed by medical studies at the University of Torino, Italy, where she graduated with top honors (110/110) in 2005. She completed a residency in Hematology (2006–2010) and earned a license as a hematology specialist in 2010. Her academic pursuits continued with a PhD in Experimental Medicine and Therapy at the University of Torino (2011–2014), supported by a grant from the Fondazione Bossolasco. Parallelly, she expanded her research capabilities through a PhD program at Karolinska Institutet, Sweden, in the Laboratory of Hematology and Regenerative Medicine. These academic experiences have equipped Dr. Giai with a robust understanding of both clinical and experimental hematology, allowing her to bridge the gap between basic science and patient-centered care. Her training reflects an international approach to hematologic research with strong foundations in molecular biology, clinical trials, and translational medicine.

💼 Professional Experience 

Dr. Valentina Giai began her clinical journey with an internship in internal medicine and hematology at the University of Torino in 2005. From 2006 to 2010, she completed her residency and fellowship in hematology at the same institution, becoming a board-certified hematologist in 2010. Her international exposure includes guest research at Karolinska Institutet in Sweden (2010–2012), where she engaged in cutting-edge hematologic research. Between 2012 and 2015, she served at the Molinette Hospital in Torino. From 2015 to 2016, she worked as a hematology consultant in Asti, followed by a tenure as attending physician in Alessandria (2015–2019). Since 2019, she has been a leading hematologist at Città della Salute e della Scienza, Torino. Across these roles, she has led clinical research, mentored junior clinicians, and collaborated on major clinical trials. Her trajectory reflects deep integration of clinical care, patient outcomes, and translational research.

🏆 Awards and Honors

Dr. Giai has been recognized for her academic and clinical excellence throughout her career. She was awarded a prestigious research grant by the Fondazione Bossolasco to pursue her PhD studies, affirming the scientific value and societal relevance of her research. Her collaborative role in the international hematology community, particularly through the Karolinska Institutet, underscores her global reputation. Many of the clinical trials she contributed to—such as QUAZAR AML-001 and studies on luspatercept and CC-486—are landmark publications in hematology and featured in journals like NEJM, JCO, and Blood. Her involvement in nationwide research networks like GIMEMA and FISiM showcases peer recognition and trust in her scientific judgment. Additionally, her contributions during the COVID-19 pandemic in the hematology context were instrumental in shaping clinical guidance in Italy. Dr. Giai’s achievements demonstrate her dedication to evidence-based medicine and advancing hematologic care.

🔬 Research Interests 

Dr. Giai’s research interests center on hematologic malignancies and disorders, particularly acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and chronic myeloid leukemia (CML). She is deeply involved in evaluating new therapeutic strategies, including targeted agents like FLT3 inhibitors and hypomethylating agents. Her work also explores the molecular biology of hematopoiesis, leukemia stem cells, and drug resistance mechanisms. She has contributed to clinical trials assessing novel compounds such as crovalimab, luspatercept, CC-486, and gilteritinib, integrating clinical outcomes with translational biomarkers. Additionally, she has explored patient-reported outcomes and quality-of-life monitoring in CML, emphasizing the humanistic dimension of care. Dr. Giai is also active in immunological studies related to SARS-CoV-2 impacts on hematologic patients. Her interdisciplinary approach aims to improve long-term outcomes by tailoring treatment strategies based on disease biology, patient fitness, and real-world efficacy data.

🧪 Research Skills

Dr. Giai brings a versatile skill set spanning clinical trials, translational research, molecular diagnostics, and biostatistics. She is adept in designing and executing multicenter clinical trials, evidenced by her involvement in pivotal Phase II and III studies. Her lab-based experience includes work with hematopoietic stem cells, oxidative stress assays, and cellular characterization using flow cytometry and molecular markers. She has collaborated on biomarker identification, particularly in MDS and AML, and has validated prognostic scoring systems and response criteria. In addition to her technical prowess, she has contributed to data management, protocol writing, and regulatory submissions for ethical approval. Her international collaboration with Karolinska Institutet reflects her ability to conduct integrative research across institutions. Moreover, her skills extend to epidemiological surveys, quality-of-life studies, and SCORE models for cardiovascular risk in hematologic settings. She combines scientific rigor with a strong patient-centered research ethos.

✅ Conclusion

Dr. Valentina Giai is a prominent clinical researcher and hematologist whose contributions span from translational benchwork to advanced clinical trials. With a strong academic foundation and consistent clinical involvement, she continues to shape the future of hematologic therapies. Her research legacy is deeply embedded in precision medicine, collaborative networks, and patient-focused innovation.

📚 Publication Top Notes

  1. Scheinberg P, … Giai V, 2024 – Crovalimab vs eculizumab in PNH (Am J Hematol)

  2. Urbino I, … Giai V, 2024 – Sorafenib for FLT3-ITD AML (Leuk Res)

  3. Mulas O, … Giai V, 2024 – SCORE2 cardiovascular risk in CML (Ann Hematol)

  4. Efficace F, … Giai V, 2024 – Symptom monitoring in CML (Cancer)

  5. Lanino L, … Giai V, 2023 – Luspatercept real-world study in MDS (Am J Hematol)

  6. Oliva EN, … Giai V, 2023 – Eltrombopag in low-risk MDS: Phase II trial (JCO)

  7. Apolito V, … Giai V, 2023 – AML mortality prediction with SIE/SIES/GITMO (Br J Haematol)

  8. Pacelli P, … Giai V, 2023 – CD26+ LSCs post-TKI discontinuation (Front Pharmacol)

  9. Garcia-Manero G, … Giai V, 2021 – CC-486 in lower-risk MDS (JCO)

  10. Wei AH, … Giai V, 2020 – Oral azacitidine for AML in remission (NEJM)

  11. Mossuto S, … Giai V, 2020 – COVID-19 in MDS: Italian experience (HemaSphere)

  12. Fenaux P, … Giai V, 2020 – Luspatercept for MDS (NEJM)

  13. Giannotta JA, … Giai V, 2022 – COVID-19 vaccination in PNH (Am J Hematol)

  14. Calabretto G, … Giai V, 2022 – Hypocellular MDS: immunologic profile (Leukemia)

  15. Giai V, … 2022 – Oxidative stress in MDS progenitors (J Biotechnol Biomed)

  16. Arrigo G, … Giai V, 2022 – Gilteritinib for breast relapse of AML (Acta Haematol)

  17. Giai V, … 2021 – Philadelphia-negative MPN overview (Medicina)

  18. Benevolo G, … Giai V, 2021 – Update on Polycythemia Vera treatments (Ther Clin Risk Manag)

  19. Frairia C, … Giai V, 2023 – SCORE and SOFA in AML (Eur J Haematol)

  20. Urbino I, … Giai V, 2023 – Levofloxacin prophylaxis in AML (Mediterr J Hematol Infect Dis)

  21. Aydin S, … Giai V, 2023 – AML fitness evaluation using HCT-CI, G8 (Cancers)

  22. Martella F, … Giai V, 2022 – Thrombosis risk in AML & MDS (Ann Hematol)

  23. Giai V, … 2016 – Imatinib discontinuation in CML (Br J Haematol)

  24. Ferrero D, … Giai V, 2009 – EPO + vitamin D in MDS anemia (Br J Haematol)

  25. Lobetti-Bodoni C, … Giai V, 2012 – Telomere loss in CML (Mech Ageing Dev)

  26. Ferrero D, … Giai V, 2014 – Maintenance chemotherapy in AML/MDS (Ann Hematol)

  27. Scharenberg C, … Giai V, 2017 – Mutations predicting del(5q) progression in MDS (Haematologica)

  28. Nikpour M, … Giai V, 2013 – ABCB7 in sideroblastic anemia (Leukemia)

Perihan AKBAŞ | Microbiology | Best Researcher Award

Posted on by Shen Awards

Assist. Prof. Dr. Perihan AKBAŞ | Microbiology | Best Researcher Award

Ondokuz Mayıs University, Turkey

Dr. Perihan Akbaş is a distinguished microbiologist and academic at Ondokuz Mayıs University, Turkey, specializing in microbiology, biotechnology, and food microbiology. With a PhD in General Biology from Atatürk University and a strong foundation in biological sciences, she has built a remarkable career centered around the investigation of natural antimicrobial agents and microbial safety in foods. Over two decades, Dr. Akbaş has contributed extensively to scientific literature with numerous articles in international peer-reviewed journals, focusing on plant extracts, peptone production from insects, and microbial food safety. Her academic leadership is reflected through her advisory roles in postgraduate theses and participation in international scientific congresses. She has also authored chapters in scholarly books, further underlining her interdisciplinary expertise. Known for her rigorous scientific methodology and innovative research, Dr. Akbaş continues to play a key role in shaping future research in applied microbiology and forensic biotechnology.

Professional Profile

Google Scholar

Scopus

Orcid

Education

Dr. Perihan Akbaş began her academic journey with a Bachelor’s degree in Biology from Atatürk University, graduating in 2002. She earned her Master’s degree in Biology (with thesis) from Kafkas University in 2004, with a thesis focused on the investigation of E. coli O157:H7 in doner kebabs sold in Kars. In 2013, she completed her Ph.D. in General Biology at Atatürk University’s Institute of Science. Her doctoral thesis explored the use of the Locusta migratoria grasshopper as a microbial peptone source, supervised by Prof. Dr. Esabi Başaran Kurbanoğlu. Her academic training provided a strong basis in microbiology, food safety, and biotechnology, laying the groundwork for her diverse research portfolio. Her educational background spans microbiological analysis, natural antimicrobial agents, microbial growth media development, and environmental biology, which collectively shape her research focus in applied and forensic sciences.

Professional Experience 

Dr. Akbaş’s academic career spans various prestigious institutions. She served as Assistant Professor at Kafkas University between April 2014 and April 2022 in the Department of Medical Services and Techniques. Since April 2022, she has held the same title at Ondokuz Mayıs University’s School of Health Services, specifically in the Pathology Laboratory Techniques program. In addition to teaching, she contributed administratively as Deputy Director of the Karadeniz Advanced Technology Application and Research Center (2022–2024). Her experience extends to supervising graduate theses on emerging topics in forensic and medical sciences. She has led and participated in multiple national and international scientific conferences and has extensive experience in academic publishing, curriculum development, and student mentoring. Dr. Akbaş’s multidisciplinary approach integrates microbiology, biochemistry, and forensic science, reflecting her commitment to high-impact research and education.

Awards and Honors 

Dr. Perihan Akbaş is widely recognized for her academic excellence and research contributions. Though individual award details are not extensively listed, her scientific impact is evident through frequent citations, international publications, and invited presentations. Her works, especially those focused on antimicrobial agents derived from plants and microorganisms, have drawn attention in the scientific community. She has also contributed to several prestigious congresses as an oral presenter and co-author, indicating peer recognition. Additionally, she has co-authored chapters in international books published by reputable publishers, such as Serüven Yayınevi and Gece Kitaplığı. Her consistent output and mentorship of postgraduate research further reflect her academic leadership. Being a regular presenter at national and international conferences and having contributed to forensic and food microbiology literature, Dr. Akbaş is regarded as a reliable scientific voice in her domain.

Research Interests

Dr. Akbaş’s research focuses on microbiology, biotechnology, and food safety. Her primary interest lies in investigating the antimicrobial and antioxidant activities of natural plant extracts, such as Peganum harmala, Rumex patientia, and Hyoscyamus reticulatus. She explores their applications in treating microbial infections and as food preservatives. Another key area is food microbiology, specifically the detection of pathogens like E. coli O157:H7 and Salmonella spp. in meat products. She also delves into the biotechnological production of microbial peptones from unconventional sources like Locusta migratoria and the use of deep eutectic solvents for bioactive compound extraction. Dr. Akbaş integrates modern analytical techniques like GC-MS/MS and XRF into her work, linking biological efficacy with chemical composition. Her interdisciplinary approach merges microbiology, toxicology, and forensic science, making her research impactful for both clinical and food safety applications.

Research Skills 

Dr. Perihan Akbaş possesses extensive skills in experimental microbiology, including antimicrobial susceptibility testing, microbial culture techniques, and food safety assessment. She is proficient in biochemical analysis methods such as GC-MS/MS, X-ray fluorescence (XRF), and spectrophotometric assays. Her expertise also includes extraction of active compounds using classical solvents and advanced deep eutectic solvents. She has hands-on experience in developing and optimizing microbial growth media from alternative nitrogen sources. Dr. Akbaş is adept at statistical analysis of biological data, manuscript preparation, and interdisciplinary research design. Her work frequently bridges forensic, environmental, and food sciences. Additionally, she demonstrates strong supervisory skills, guiding MSc and PhD students in developing scientifically sound and ethically approved research. She actively participates in scientific writing, peer reviewing, and interdisciplinary collaboration, making her a versatile and impactful researcher.

Conclusion

Dr. Perihan Akbaş is a prominent academic whose interdisciplinary expertise spans microbiology, biotechnology, food safety, and forensic sciences. Her innovative research, dedication to academic mentorship, and continuous contributions to scientific literature make her a respected figure in the scientific community. Her ability to blend practical applications with fundamental research reflects her value as both a scientist and educator.

Publication Top Notes

  1. Akbaş P., Kaya E., Makav M., Yıldız G. (2023). Antimicrobial and antioxidant activities of Chenopodium album extracts.

  2. Kaya E., Akbaş P. (2023). Antimicrobial, antioxidant activities and fatty acid composition of Peganum harmala Seed.

  3. Akbaş P., Kurbanoğlu E.B. (2022). Locusta migratoria as a nitrogen source for microbial growth.

  4. Alkan H., Akbaş P., Durhan S., Öztürkler O. (2021). Antimicrobial activity of horseradish root.

  5. Kaya E., Akbaş P., et al. (2020). Fatty acid composition of Rumex patientia and antimicrobial activity.

  6. Akbaş P., Uslu H., et al. (2020). Antimicrobial and apoptotic activity of Hyoscyamus reticulatus.

  7. Akbaş P., Kaya E., et al. (2020). XRF and antibacterial characteristics of Hyoscyamus reticulatus seeds.

  8. Alkan H., Akbaş P., et al. (2017). Assertiveness level of health services vocational school students.

  9. Akbaş P., Gürsoy Kol Ö., et al. (2017). Antimicrobial and antioxidant activity of watermelon and seeds.

  10. Gürbüz A., Akbaş P. (2015). Antibiotic susceptibility of Pseudomonas aeruginosa from bovine lungs.

  11. Ulukanlı Z., Akbaş P., Tuzcu M. (2006). E. coli O157:H7 in doner kebabs in Kars.

  12. Elmali M., Ulukanlı Z., et al., Akbaş P. (2005). E. coli O157:H7 detection from ground beef in Turkey.

  13. Elmali M., Ulukanlı Z., et al., Akbaş P. (2005). Microbiological quality of beef doner kebabs in Turkey.

Gollapalle Lakshminarayanshastry Viswanatha | Pharmacology | Best Researcher Award

Posted on by Shen Awards

Dr. Gollapalle Lakshminarayanshastry Viswanatha | Pharmacology | Best Researcher Award

Manipal College of Pharmaceutical Sciences, MAHE, Manipal, India

Dr. Gollapalle L. Viswanatha is a distinguished pharmacologist and toxicologist with over 17 years of expertise in pharmaceutical R&D, regulatory toxicology, and preclinical research. Currently serving as a Manager at ClinChoice Pvt. Ltd., Bengaluru, he has held pivotal roles in organizations like IQVIA, The Himalaya Drug Company, and Connexios Life Sciences. A prolific academic and industry contributor, Dr. Viswanatha has authored over 100 peer-reviewed articles and delivered more than 20 expert talks in global forums. As a DABT-certified and European Registered Toxicologist (ERT), his work bridges cutting-edge science with regulatory excellence. He also serves as adjunct faculty at Manipal College of Pharmaceutical Sciences, mentoring postgraduate students and contributing to academic research. His pioneering efforts in herbal drug evaluation, regulatory documentation, and systematic reviews make him a leading voice in toxicology and pharmacology. With several novel animal models to his credit, he actively influences drug discovery and translational medicine.

Professional Profile

Google scholar

Scopus

Orcid

Educational 

Dr. Viswanatha holds a PhD in Pharmaceutical Sciences (2019) from JNTU Anantapur, with a dissertation focused on indigenous medicinal plants against stroke and epilepsy. He is board-certified by the American Board of Toxicology (DABT, 2023) and recognized as a European Registered Toxicologist (ERT, 2022). He completed a PG Diploma in Statistical Quality Control and earned a Six Sigma Green Belt from the Indian Statistical Institute (ISI), Bengaluru in 2017, both with Grade ‘A’. He holds an M. Pharm in Pharmacology (2008) from RGUHS, Bengaluru, graduating with 77% and was honored as the Best Outgoing Student. Additionally, he is a GATE and GPAT qualifier. His academic foundation is marked by a multidisciplinary understanding of pharmacology, quality systems, and toxicology. Throughout his academic journey, he has demonstrated a commitment to both practical research and methodological rigor, blending statistical competence with clinical relevance in drug discovery and safety sciences.

Professional Experience

Dr. Viswanatha has a robust professional background spanning regulatory toxicology, preclinical pharmacology, and data surveillance. Currently, he leads the toxicology division at ClinChoice Pvt. Ltd. (2021–present), overseeing cosmetic ingredient safety, CTD preparation, biocompatibility risk assessments, and toxicological risk evaluations. He formerly worked at IQVIA India Pvt. Ltd. (2014–2021) as a Senior Medical Data Reviewer, specializing in clinical trial surveillance and protocol compliance for myocardial infarction studies. Prior to that, he served as a Research Associate at The Himalaya Drug Company (2010–2014), standardizing herbal drug models, and as a Scientist at Connexios Life Sciences (2008–2010), handling PK, safety pharmacology, and toxicological assessments of NCEs. His interdisciplinary approach combines GLP compliance, regulatory documentation, safety evaluations, and project leadership. With broad expertise across pharmaceuticals, nutraceuticals, and cosmetics, he has contributed to product development from discovery to regulatory submission while mentoring cross-functional teams and managing end-to-end project execution.

Awards and Honors 

Dr. Viswanatha has received numerous accolades throughout his academic and professional journey. He was honored with the prestigious Joe-Mae International Young Scientist Award by the AMS Society in Hong Kong (2016) and was a nominee for the Dr. Achari Award at IPSCON 2012 for his work on a novel pharyngitis animal model. He earned the title of Best Outgoing Student during his M. Pharm (2006–2008) and successfully qualified in GATE 2007, GPAT 2010 & 2011. His innovative contributions include the development of novel animal models for non-infectious pharyngitis and hemorrhoids. He has been invited for over 10 expert talks, delivered 5 hands-on workshops, and reviewed articles for over 35 high-impact journals, reflecting his standing as a respected thought leader. These honors underscore his commitment to translational pharmacology, scientific innovation, and academic mentorship, bridging traditional medicine with modern pharmacological practices.

Research Interests 

Dr. Viswanatha’s research interests span preclinical pharmacology, regulatory toxicology, herbal medicine, and evidence-based drug evaluation. His work focuses on stroke, epilepsy, neurodegeneration, nephroprotection, pharyngitis, and gastrointestinal and cardiovascular pharmacology, often using rodent models. He has a strong inclination toward toxicological risk assessment (TRA), biocompatibility studies, and regulatory documentation for pharmaceuticals and cosmetics. His current pursuits involve systematic reviews and meta-analyses on both clinical and preclinical data, particularly emphasizing GABAergic modulation, anti-inflammatory agents, and flavonoids like naringin. He also contributes to safety pharmacology and real-world evidence generation. Beyond therapeutic investigations, he’s deeply involved in OECD-compliant toxicology, SCCS cosmetic safety dossiers, and ISO 10993-based device safety evaluations. His dual strength in bench science and regulatory frameworks makes his research both impactful and implementation-ready, aligning traditional pharmacological principles with global safety standards.

Research Skills

Dr. Viswanatha possesses advanced skills in in vivo and in vitro pharmacological/toxicological experimentation, including GLP-compliant animal models using rats, mice, rabbits, and guinea pigs. He is proficient in conducting acute, repeated dose, and genotoxicity studies, and safety pharmacology evaluations per ICH guidelines. He excels in meta-analysis and systematic reviews using RevMan, RoB-2, G-Power, and Newcastle-Ottawa scales, alongside regulatory documentation (CTD modules 2.4 & 2.6, CPSR, ADE/PDE/OEL assessments). He has expertise in SCCS guidelines, QSAR & AOT software tools, and data analysis using GraphPad Prism, SPSS, and Minitab. He’s also skilled in toxicological literature mining using PubMed, ECHA, PubChem, and other databases. A Six Sigma Green Belt and SQC professional, his approach blends quality systems with analytical rigor. His research strengths lie in project management, protocol development, real-world evidence integration, and regulatory toxicology strategy, making him an asset across life sciences domains.

Conclusion

Dr. Viswanatha exemplifies a rare blend of rigorous experimental pharmacology and robust regulatory toxicology. His multidisciplinary education and certifications, from PhD to international toxicology credentials, underpin his leadership in both academic and industry domains. With a strong track record in innovative animal model development, systematic reviews, and regulatory documentation, he drives preclinical-to-clinical translation effectively. His prolific publication record, awards, and advisory roles highlight a distinguished career that continues to influence global life sciences.

 Publication Top Notes

  • 🧠 Clinical study on cisplatin‑induced nephrotoxicity in humans – PA Arunkumar et al. (2012)

  • 🌿 Ethnopharmacology of Lepidium sativum Linn: A review – D Manohar et al. (2012)

  • 🍃 Antioxidant & anti-inflammatory activity of Mangifera indica leaf extracts – CG Mohan et al. (2013)

  • 🍊 Naringin’s neuroprotective neurobehavioral review/meta-analysis – GL Viswanatha et al. (2017)

  • 🍎 Isolation of antidiabetic principle from Punica granatum rinds – V Jain et al. (2012)

  • 🌳 POG‑glucose inhibits 11β‑HSD‑1 & ameliorates diet-induced diabetes – CG Mohan et al. (2013)

  • 🍋 Lemongrass oil for dexamethasone-induced hyperlipidemia – VRS Kumar et al. (2011)

  • 💊 Hepatoprotective activity of Hepax polyherbal formulation – VC Devaraj et al. (2011)

  • 🌿 Antioxidant & antimutagenic activities of Terminalia arjuna bark – GL Viswanatha et al. (2013)

  • 🩸 Rat model of hemorrhoids: anti‑hemorrhoidal study – M Azeemuddin et al. (2014)

  • 💧 LC‑MS/MS quantification of flavonoids in Moringa & Raphinus – VC Devaraj et al. (2011)

  • 🧠 Animal models of chemotherapy‑induced cognitive decline – J John et al. (2021)

  • 💡 Bacopa monnieri + rivastigmine memory reversal in rats – AHM Thippeswamy et al. (2016)

  • 🍊 Hesperidin’s neuroprotective & mitochondrial benefits – GL Viswanatha et al. (2012)

  • ⚡ Anti‑epileptic activity of Punica granatum leaf extracts – GL Viswanatha et al. (2016)

  • 🌲 Anxiolytic & anticonvulsant activity of Cedrus deodara – GL Viswanatha et al. (2009)

  • 🧠 POG‑glucose alleviates ischemia/reperfusion brain injury – GL Viswanatha et al. (2013)

  • 🧪 Anti‑ulcer effect of Raphinus sativus leaves – VC Devaraj et al. (2011)

  • 🌱 Gymnema sylvestre extract improves glucose uptake – PM Kumar et al. (2016)

  • 🍇 Phytochemical standardization of Punica granatum – V Jain et al. (2011)

  • 🌸 Anti‑fertility activity of Tabernaemontana divaricata flowers – MA Mukhram et al. (2012)

  • 🧊 Anti‑urolithiatic effect of Cedrus deodara extract – N Krishnadas et al. (2010)

  • 💩 Antidiarrheal activity of Thespesia populnea bark fractions – GL Viswanatha et al. (2011)

  • 🦴 Anti‑osteoporotic effect of herbal formula NR/CAL/06 – P Srikanta et al. (2011)

  • 🌿 Antidiarrheal activity of Lepidium sativum seed extract – D Manohar et al. (2011)

  • 🧠 Acteoside from Colebrookea – anti‑epileptic effects – GL Viswanatha et al. (2016)

  • 💊 Thienotriazines: synthesis & antihistaminic activity – GL Viswanatha et al. (2012)

  • 🧠 Punica granatum extract protects against I/R brain injury – GL Viswanatha et al. (2014)

  • 🌱 Colebrookea oppositifolia root for stroke – cerebroprotective effect – GL Viswanatha et al. (2019)

  • 💥 Anticonvulsant activity of POG‑glucose from Mangifera indica – GL Viswanatha et al. (2018)

  • 💊 Mechanisms of biochanin‑A: a pharmacological review – PV Anuranjana et al. (2010)

  • 🧬 Diabetic wound healing: update – R Keni et al. (2012)

  • 🛡️ Cardioprotective preclinical systematic review on naringin – GL Viswanatha et al. (2023)

  • 🌿 Ethnopharmacology of Lepidium sativum Linn. review – M Divanji et al. (2022)

  • 🧠 Erythrina variegata bark extract: anxiolytic & anticonvulsant – G Pitchaiah et al. (2023)

 

Xialiang Li | Chemistry | Best Researcher Award

Posted on by Shen Awards

Mr. Xialiang Li | Chemistry | Best Researcher Award

Associate Professor from Shaanxi Normal University, China

Dr. Xialiang Li is an accomplished scholar and Associate Professor at the School of Chemistry and Chemical Engineering, Shaanxi Normal University, China. He serves as the chief professor and doctoral supervisor of the molecular simulation and solar energy conversion research team. His academic focus lies primarily in the intersection of chemistry and energy sciences, particularly targeting small molecule activation processes for sustainable energy applications. Dr. Li is widely recognized for his methodical approach to the synthesis and characterization of molecular complexes and solid-state materials. His work involves a balanced combination of theoretical insights and practical experimentation, aimed at resolving critical challenges in the fields of catalysis and bioinorganic chemistry. Over the years, he has built an extensive portfolio of high-impact publications in leading international journals, including the Journal of the American Chemical Society, Angewandte Chemie International Edition, and ACS Catalysis. Dr. Li’s ongoing efforts are supported by several national-level funding agencies, and he continues to contribute significantly to the academic landscape through mentoring, research leadership, and active participation in advanced scientific projects. His expertise, dedication to excellence, and forward-looking research trajectory make him a strong contender for prestigious recognitions such as the Best Researcher Award.

Professional Profile

Education

Dr. Xialiang Li has a robust academic foundation, built through successive degrees from reputable Chinese institutions. He began his academic journey at Changchun University of Science and Technology, where he earned his Bachelor’s degree from 2009 to 2013. During this period, he gained fundamental knowledge and developed an early interest in chemistry and materials science. He continued his postgraduate studies at Lanzhou Jiaotong University, where he pursued a Master’s degree from 2013 to 2016. There, he delved deeper into specialized research methodologies, analytical techniques, and experimental approaches that prepared him for advanced research. To further enhance his expertise and explore complex topics in energy conversion and catalysis, Dr. Li enrolled at Shaanxi Normal University for his doctoral studies, which he completed between 2016 and 2019. His Ph.D. research was instrumental in shaping his long-term academic trajectory, leading to significant contributions in bioinorganic chemistry and molecular catalysis. Throughout his education, Dr. Li consistently demonstrated academic excellence, innovative thinking, and a strong commitment to pushing the boundaries of scientific knowledge. His educational path reflects a well-rounded and focused progression that has equipped him with the skills and perspective necessary for high-impact research in energy-related chemical sciences.

Professional Experience

Dr. Xialiang Li has accumulated a range of academic and research experiences that underscore his professional growth and leadership in the field of chemistry. After obtaining his doctoral degree in 2019, he joined Shaanxi Normal University as a postdoctoral researcher, a position he held until 2022. During this phase, he expanded his research activities into new areas, working on high-priority projects related to small molecule activation and catalysis. His postdoctoral work solidified his expertise in cutting-edge techniques such as spectroscopic analysis, crystallography, and electrochemical testing, allowing him to produce insightful findings on catalytic mechanisms. In 2022, he was promoted to the role of Associate Professor at the same institution, a testament to his academic achievements and growing reputation as a research leader. In this capacity, he supervises doctoral candidates, coordinates interdisciplinary projects, and leads a dynamic research group dedicated to solar energy conversion. His work has been supported by major funding sources, and he continues to contribute to the university’s mission through teaching, mentoring, and scientific collaboration. Dr. Li’s professional journey demonstrates a steady and impactful progression, marked by academic rigor, leadership ability, and dedication to solving pressing energy-related challenges through innovative chemical research.

Research Interests

Dr. Xialiang Li’s research interests are centered on bioinorganic chemistry and catalysis, with a primary focus on energy-related small molecule activation. He is particularly interested in the design, synthesis, and functionalization of molecular complexes and solid-state materials that can serve as efficient catalysts for processes such as water splitting, oxygen reduction, and carbon dioxide reduction. These reactions are critical to sustainable energy conversion and storage technologies, including hydrogen production and carbon capture. At the core of his research is a desire to understand and manipulate the underlying principles of catalysis to improve efficiency and selectivity. As the head of the molecular simulation and solar energy conversion team at Shaanxi Normal University, he leads investigations that integrate experimental and computational approaches to explore structure–activity relationships. His work involves leveraging crystallographic data, electrochemical behavior, and spectroscopic signatures to derive mechanistic insights that can inform the design of next-generation catalytic systems. Dr. Li’s research not only contributes to fundamental chemical knowledge but also offers practical solutions to real-world energy challenges. By focusing on catalytic innovations with broad environmental and industrial applications, he stands at the forefront of a transformative area of modern chemistry.

Research Skills

Dr. Xialiang Li possesses a comprehensive set of research skills that position him as a leading expert in the field of catalytic energy conversion. His core competencies include the synthesis of molecular and solid-state materials, crystallographic analysis, and a range of advanced electrochemical techniques. He is proficient in the use of multiple spectroscopic methods, such as UV-Vis, FTIR, NMR, and EPR, which allow him to characterize the electronic structure and reactive behavior of catalytic systems in detail. His ability to connect structural features with catalytic performance enables him to establish precise structure–activity relationships, which are essential for rational catalyst design. In addition, Dr. Li has extensive experience in computational modeling and molecular simulation, tools that complement his experimental work by offering predictive insights into reaction mechanisms and kinetics. His methodological rigor is supported by a strong foundation in physical chemistry and thermodynamics, which he applies to optimize catalyst efficiency under practical conditions. These versatile skills empower him to tackle complex research questions, develop novel materials, and push the boundaries of what is achievable in green and sustainable chemistry. His integrated approach reflects a balance between theoretical understanding and practical application.

Awards and Honors

Dr. Xialiang Li’s scholarly excellence has been recognized through various national and institutional awards, research grants, and honors. His work has attracted funding from several prestigious organizations, including the National Natural Science Foundation of China and the China Postdoctoral Science Foundation. These grants not only reflect the innovative nature of his proposals but also his ability to deliver high-impact results in strategically important research areas. In addition to these national-level grants, Dr. Li has received internal support from Shaanxi Normal University under its Fundamental Research Funds for the Central Universities program, which supports cutting-edge investigations in emerging scientific fields. While he has not listed specific award titles, his publication record in top-tier journals such as Angewandte Chemie, JACS, ACS Catalysis, and Accounts of Chemical Research stands as a testament to his scholarly recognition in the global chemistry community. His research achievements have also led to his appointment as a doctoral supervisor and key faculty member within his institution. Dr. Li’s growing influence, backed by strong funding and consistent publication output, underscores his status as a rising star in the field of catalysis and sustainable chemistry.

Conclusion

Dr. Xialiang Li is a distinguished academic whose work bridges fundamental chemistry and applied energy science. His trajectory from a strong academic foundation to a leadership role in research demonstrates consistent growth, innovation, and impact. He has successfully developed a research niche in bioinorganic catalysis, tackling some of the most urgent global challenges related to clean energy and environmental sustainability. His ability to secure competitive research funding, publish in leading international journals, and lead a vibrant research team reflects his commitment to scientific advancement and academic excellence. While there is still room for expanding international collaborations and industrial applications, his current portfolio already positions him as a strong candidate for broader scientific recognition. By combining deep technical expertise with a clear vision for the future of sustainable chemistry, Dr. Li embodies the ideals of a modern scientific leader. He is highly deserving of the Best Researcher Award, not only for his research contributions but also for his potential to shape future directions in catalytic science and energy conversion technologies. His continued work is expected to deliver both theoretical breakthroughs and practical innovations with long-term global relevance.

Publications Top Notes

  • Electrocatalytic Syngas Production Using Metalloporphyrins with Controllable H₂/CO Ratios
    Authors: Zhimeng Wang, Benxing Mei, Yuhan Xu, Yuze Liu, Xialiang Li, Rui Cao
    Year: 2025
  • Improving Electrocatalytic CO₂ Reduction over Iron Tetraphenylporphyrin with Triethanolamine as a CO₂ Shuttle
    Authors: Zhiyuan Yin, Mengchun Zhang, Yuchi Long, Haitao Lei, Xialiang Li, Xue-Peng Zhang, Wei Zhang, Ulf-Peter Apfel, Rui Cao
    Year: 2025
  • Revealing Significant Electronic Effects on the Oxygen Reduction Reaction with Iron Porphyrins
    Authors: Zhiyuan Yin, Yuchi Long, Haitao Lei, Xue-Peng Zhang, Xialiang Li, Rui Cao
    Year: 2025

Justine Badee | Drug Metabolism | Best Researcher Award

Posted on by Shen Awards

Dr. Justine Badee | Drug Metabolism | Best Researcher Award

Scientist from Novartis, Switzerland

Dr. Justine Badée is a distinguished pharmacokinetics researcher with over eight years of experience in the pharmaceutical industry, primarily focusing on physiologically-based pharmacokinetic (PBPK) modeling. Currently serving as a Principal Scientist II at Novartis in Basel, Switzerland, she leads modeling efforts to support drug development from First-in-Human studies to regulatory submissions. Dr. Badée holds a Ph.D. in Pharmacokinetics and Drug Metabolism from the University of Manchester and has a strong foundation as a pharmacist and researcher. Her work encompasses a wide range of applications including drug-drug interactions, pediatric dosing, lactation modeling, and biopharmaceutic assessments. In addition to her scientific contributions, she has mentored Ph.D. students, driven external collaborations with international organizations such as Simcyp and the IQ Consortium, and delivered presentations at leading global conferences. Her multi-disciplinary approach and applied modeling expertise have led to significant advancements in PBPK methodologies and their regulatory application. Dr. Badée has authored and co-authored numerous scientific publications and contributed actively to the development of industry best practices in pharmacokinetics. She is recognized not only for her technical excellence but also for her leadership, mentoring, and collaborative spirit, making her a key contributor to the field of clinical pharmacology and drug metabolism.

Professional Profile

Education

Justine Badée possesses a comprehensive and rigorous academic background in pharmacokinetics and pharmaceutical sciences. She completed her Ph.D. in Pharmacokinetics and Drug Metabolism at the Centre for Applied Pharmacokinetic Research (CAPkR), University of Manchester, UK, where she focused on hepatic uptake clearance and its in vitro to in vivo translation. Her research was supported by joint funding from AstraZeneca and the UK Biotechnology and Biological Sciences Research Council. Prior to her doctoral studies, she earned a Master’s degree in Pharmacokinetics from the Faculty of Pharmacy at University René Descartes V in Paris, France. Additionally, she holds a pharmacy degree from the same institution, completing her training as a licensed pharmacist. Her academic foundation was further strengthened by a scientific high school diploma with a physics major from Saint-Erembert High School in France. Dr. Badée’s academic journey has not only equipped her with a solid theoretical and experimental knowledge base but also cultivated a robust understanding of pharmacological principles and translational research. Her diverse educational pathway—spanning pharmaceutical sciences, clinical pharmacokinetics, and drug metabolism—has played a critical role in her ability to engage in complex modeling tasks and collaborative international research efforts in drug development.

Professional Experience

Dr. Justine Badée’s professional experience reflects a dynamic and upward trajectory in the pharmaceutical and academic sectors. Since 2019, she has been a Clinical PBPK Modeler and Principal Scientist II at Novartis in Basel, where she applies PBPK modeling to a range of clinical drug development scenarios, including DDI predictions, population-specific dosing, and regulatory submissions. She also completed a three-month managerial rotation as a Project Team Manager in oncology, supporting protocol design and pharmacokinetic analysis. Her prior postdoctoral work was jointly conducted at the Center for Pharmacometrics and Systems Pharmacology, University of Florida, and at Hoffmann-La Roche, where she advanced pediatric dose selection by investigating UGT enzyme ontogeny. As a Ph.D. student at the University of Manchester, she led projects on hepatic uptake clearance and nonlinear mixed-effects modeling. Earlier in her career, she held internships at Novartis and INSERM and served as an extern pharmacist at Beaujon Hospital in Paris. Across roles, she has integrated bench research, computational modeling, and clinical applications, resulting in a comprehensive skill set. Her trajectory from laboratory-based research to high-level modeling in an industrial setting exemplifies her adaptability, technical expertise, and commitment to translating pharmacokinetic theory into practice.

Research Interests

Dr. Badée’s research interests lie at the intersection of pharmacokinetics, drug metabolism, and translational modeling. A key focus of her work is the development and application of physiologically-based pharmacokinetic (PBPK) models to optimize drug dosing, predict drug-drug interactions, and inform regulatory decisions. She is particularly interested in special populations—pediatrics, lactating women, and patients with hepatic or renal impairment—where traditional pharmacokinetic approaches often fall short. Her research extends into enzyme ontogeny, especially hepatic UGT isoforms, and how their developmental profiles affect drug metabolism across life stages. Dr. Badée is also engaged in refining in vitro methodologies to better predict in vivo drug behavior, with a focus on improving the reliability of automated glucuronidation assays. Her interest in translational research is evident through her active involvement in industry consortia and collaborative initiatives aimed at improving PBPK workflows and regulatory confidence. Furthermore, she explores innovative model-based approaches to address complex drug development challenges, such as enzyme induction and transporter-mediated drug disposition. Through these pursuits, she contributes to bridging gaps between laboratory findings, clinical implementation, and regulatory science, demonstrating a keen interest in both theoretical development and real-world application of pharmacokinetic modeling.

Research Skills

Dr. Justine Badée possesses a robust portfolio of research skills spanning pharmacokinetic modeling, laboratory techniques, and collaborative project execution. Her core technical competencies include physiologically-based pharmacokinetic (PBPK) modeling using tools such as Simcyp, GastroPlus, and PK-Sim, as well as nonlinear mixed-effect (NLME) modeling with NONMEM. She is adept at both population pharmacokinetics and PK/PD modeling, utilizing software such as WinNonlin/Phoenix, GraphPad Prism, and R. In laboratory settings, she has conducted molecular biology experiments, bioanalytical quantification using LC-MS/MS, protein assays, and hepatocyte isolation, among others. Her experience includes designing and optimizing in vitro uptake and glucuronidation assays to model hepatic metabolism accurately. Dr. Badée’s skills extend beyond the bench and computational tasks—she is also a skilled scientific communicator and collaborator. She has mentored Ph.D. students, led cross-functional teams, and actively participated in international scientific workshops and training programs. Her ability to integrate laboratory findings into advanced modeling platforms reflects her interdisciplinary expertise. Collectively, these skills position her as a valuable contributor to both the academic and industry research ecosystems, ensuring she can translate complex scientific questions into actionable insights for drug development and regulatory strategy.

Awards and Honors

Throughout her career, Dr. Justine Badée has received multiple prestigious awards and recognitions for her scientific excellence and research impact. These include the IQ Recognition Award (2021), the American College of Clinical Pharmacology (ACCP) Wayne A. Colburn Memorial Award (2018), and the ACCP Student Award. Her poster presentations have consistently garnered top honors, winning first-place awards at the Drug Metabolism Discussion Group (DMDG) and Group of Metabolism and Pharmacokinetics (GMP) meetings in 2013 and 2014. In 2023, she received a poster award at the Marbach Drug-Drug Interaction Workshop, further underscoring her contributions to advancing PBPK modeling. In addition to these accolades, she received a certificate of outstanding reviewer for the European Journal of Pharmaceutical Sciences in 2018, recognizing her critical evaluation and contribution to scientific literature. These awards reflect both the scientific rigor and practical relevance of her research. Her consistent recognition by professional bodies and conference committees highlights her leadership in modeling-based drug development and her commitment to excellence in pharmacological science. Dr. Badée’s accolades not only mark her individual achievements but also affirm her role in shaping current and future best practices in pharmacokinetic research.

Conclusion

In conclusion, Dr. Justine Badée represents a rare combination of scientific depth, practical impact, and collaborative leadership in the field of pharmacokinetics. Her contributions span the full spectrum of drug development—from mechanistic in vitro studies to sophisticated PBPK modeling and regulatory submissions. She has successfully bridged academia and industry, delivering actionable solutions to complex pharmacokinetic challenges. Her numerous peer-reviewed publications, awards, and leadership in international collaborations reflect a researcher deeply engaged in advancing the field and mentoring the next generation. With her ability to innovate, communicate, and translate science into therapeutic outcomes, Dr. Badée has established herself as a leading figure in modeling and simulation. Her work not only informs clinical and regulatory decisions but also contributes to safer and more effective drug use in vulnerable populations. As she continues to build on this strong foundation, her career promises further innovations in model-informed drug development. Dr. Badée is an ideal candidate for recognition through the Best Researcher Award, and her work exemplifies the highest standards of scientific inquiry and professional dedication.

Publications Top Notes

  • Predicting Drug Transfer into Human Milk with the Simcyp Simulator: A contribution from the ConcePTION Project
    Macente J, Nauwelaerts N, Badée J, Huang MC, Hernandes Bonan R, Van Neste M, Smits A, Allegaert K, Severino Martins F, Annaert P.
    2025

  • Building Confidence in Physiologically Based Pharmacokinetic Modeling of CYP3A Induction Mediated by Rifampin: An Industry Perspective
    Reddy MB, Cabalu TD, de Zwart L, Ramsden D, Dowty ME, Taskar KS, Badée J, Bolleddula J, Boulu L, Fu Q, Kotsuma M, Leblanc AF, Lewis G, Liang G, Parrott N, Pilla Reddy V, Prakash C, Shah K, Umehara K, Mupkherjee D, Rehmel J, Hariparsad N.
    2025

  • Generic workflow to predict medicine concentrations in human milk using physiologically-based pharmacokinetic (PBPK) modelling – A contribution from the concePTION project
    Nauwelaerts N, Macente J, Hernandes Bonan R, Huang MC, Van Neste M, Bibi D, Badée J, Martins FS, Smiths A, Allegaert K, Bouillon T, Annaert P.
    2023

  • Current Practices, Gap Analysis, and Proposed Workflows for PBPK Modeling of Cytochrome P450 Induction: An Industry Perspective
    Hariparsad N, Ramsden D, Taskar K, Badée J, Venkatakrishnan K, Reddy MB, Cabalu T, Mukherjee D, Rehmel J, Bolleddula J, Emani Riedmaier A, Prakash C, Chanteux H, Mao J, Umehara K, Shah K, De Zwart L, Dowty M, Kotsuma M, Li M, Pilla Reddy V, McGinnity DF, Parrott N.
    2021

  • Characterization of Hepatic UDP-Glucuronosyl Transferase Enzymes Abundance – Activity Correlations and Population Variability using a Proteomics Approach and Comparison with Cytochrome P450 Enzymes
    Takahashi RH, Forrest W, Smith AD, Badée J, Qiu N, Schmidt S, Collier CA, Parrott N, Fowler S.
    2021

  • Ontogeny of Hepatic Transporters and Drug-Metabolizing Enzymes in Humans and in Nonclinical Species
    van Groen BD, Nicolaï J, Kuik AC, van Cruchten S, van Peer E, Schmidt S, de Wildt SN, Allegaert K, de Schaepdrijver L, Annaert P, Badée J.
    2021

  • Paediatric pharmacokinetics and dose predictions: a report of a satellite meeting to the 10th Juvenile Toxicity Symposium
    van Groen BD, Pilla Reddy V, Badée J, Olivares-Morales A, Johnson TN, Nicolaï J, Annaert P, Smits A, de Wildt SN, Knibbe CAJ, de Zwart L.
    2021

  • Co-expression of human hepatic uridine diphosphate glucuronosyltransferase (UGT) proteins: Implications for ontogenetic mechanisms and isoform co-regulation
    Liu Y, Badée J, Takahashi RH, Schmidt S, Parrott N, Fowler S, Mackenzie PI, Coughtrie MWH, Collier AC.
    2020

  • Use of Phenotypically Poor Metaboliser Individual Donor Human Liver Microsomes to Identify Selective Substrates of UGT2B10
    Milani N, Qiu N, Molitor B, Badée J, Cruciani G, Fowler S.
    2020

  • Characterization of the Ontogeny of Hepatic UDP-Glucuronosyl Transferase Enzymes Based on Glucuronidation Activity Measured in Human Liver Microsomes
    Badée J, Qiu N, Collier CA, Takahashi RH, Forrest W, Parrott N, Schmidt S, Fowler S.
    2019

Yijun Xiao | Computer Science | Best Researcher Award

Posted on by Shen Awards

Mr. Yijun Xiao | Computer Science | Best Researcher Award

China University of Petroleum (East China), China 

Yijun Xiao is a highly motivated and innovative Ph.D. candidate at the China University of Petroleum (East China), known for his groundbreaking research at the intersection of computer science and molecular biology. His academic journey reflects a trajectory of excellence, transitioning from a master’s degree at Dalian University of Technology to advanced doctoral research focused on DNA computing and molecular neural networks. His recent work on programmable DNA-based molecular biocomputing circuits, published in Advanced Science, highlights his dedication to solving complex computational problems using biological substrates. Xiao’s research contributions are recognized internationally, with several publications in SCI-indexed journals and presentations at prestigious conferences like the IEEE Smart World Congress and the International Conference on Industrial Artificial Intelligence. He is not only a productive researcher but also a contributor to academic discourse through editorial roles in high-impact journals. With four patents and six journal articles to his name, his academic footprint is notable for a researcher at this stage. Xiao exemplifies the profile of a next-generation scientist poised to lead in the development of unconventional and bio-inspired computing technologies, making significant strides in non-silicon computing solutions with real-world applications in life sciences and bioinformatics.

Professional Profile

Education

Yijun Xiao earned his Master’s degree in Computer Science and Technology from Dalian University of Technology in 2023. This educational foundation equipped him with in-depth knowledge in algorithm design, artificial intelligence, and computational modeling. Currently, he is pursuing a Ph.D. at the China University of Petroleum (East China), where he focuses on interdisciplinary research involving computer science, molecular biology, and systems engineering. His doctoral work is centered around DNA computing, biochemical reaction networks, and the development of molecular controllers capable of solving high-level computational problems. The transition from a traditional computing background to a molecular computing framework reflects his adaptability and willingness to explore unconventional approaches to computing. His academic journey demonstrates a clear progression in specialization, from general computer science toward highly niche domains such as biochemical neural networks. Xiao’s education not only highlights strong academic performance but also his ability to integrate knowledge from multiple domains—a critical asset in research-intensive environments. With training grounded in both theoretical foundations and experimental research, Xiao is academically equipped to lead cutting-edge work in computational biology, unconventional computing, and interdisciplinary problem-solving.

Professional Experience

Although still in the early stages of his academic career, Yijun Xiao has demonstrated extensive professional engagement through his research and publication work. As a doctoral candidate, his primary professional responsibility involves conducting high-level scientific research that bridges computer science with biochemistry and molecular biology. He has played a lead role in designing and modeling programmable DNA-based biocomputing circuits that solve partial differential equations—an ambitious and novel application of bio-computation. His involvement in multiple international conferences, such as the IEEE Smart World Congress and the International Conference on Industrial Artificial Intelligence, reflects both his presentation skills and his readiness to contribute to global academic discourse. In addition to his research roles, he has participated in editorial duties for major journals like Advanced Science, IEEE Transactions on Nanobioscience, and IEEE Access, suggesting peer recognition of his scientific rigor and subject matter expertise. Furthermore, Xiao has authored and co-authored six SCI-indexed journal articles and has filed four patents, demonstrating both scholarly and applied research contributions. His professional experience, although rooted in academia, already exhibits a maturity and productivity that align with established researchers, signaling his readiness for broader leadership roles in future academic or research-intensive industry positions.

Research Interest

Yijun Xiao’s primary research interests lie in the domains of DNA computing, biochemical reaction networks, molecular controllers, and unconventional computing systems. His work focuses on leveraging the intrinsic parallelism of molecular systems to address computational problems that are traditionally solved using electronic and silicon-based technologies. One of his central interests involves the design and implementation of programmable DNA-based circuits capable of solving partial differential equations—a feat that merges molecular biology with complex mathematical modeling. He is particularly fascinated by the prospect of developing non-silicon-based computational architectures that mimic biological systems. This interest extends to synthetic biology, where his research could pave the way for bio-hybrid computing devices that function in tandem with natural biological processes. Xiao’s interdisciplinary curiosity drives him to explore how biomolecular substrates can be used not only for information storage and processing but also for autonomous control within chemical environments. His long-term goal is to create biocompatible computing systems that can be embedded in real-life biological contexts such as smart therapeutics, biosensing, and environmental diagnostics. The novelty and real-world applicability of his interests set him apart as a visionary in the rapidly evolving field of molecular and bio-inspired computing.

Research Skills

Yijun Xiao possesses an exceptional range of research skills that complement his interdisciplinary focus. His technical skills span computational modeling, algorithmic development, and system simulations, particularly within the context of DNA computing and biochemical reaction networks. He is adept at designing molecular circuits that perform logical and mathematical operations at the nanoscale. His experimental skills include working with DNA strands, implementing synthetic biochemical networks, and testing molecular controllers in simulated environments. Xiao is also proficient in data analysis, statistical modeling, and simulation tools, all of which are critical for validating theoretical models in biochemical systems. In addition to laboratory and computational capabilities, he demonstrates strong academic writing and peer-review skills, evidenced by his publications in high-impact journals and editorial responsibilities. He also exhibits strong collaborative skills, as seen in his partnerships with researchers from institutions like Dalian University. These collaborations have enabled him to broaden his methodological toolkit and approach problems from diverse scientific perspectives. His fluency in interdisciplinary communication allows him to translate complex concepts across domains, a rare and valuable skill in modern scientific research. Overall, Xiao’s research skills reflect a harmonious blend of theory, experimentation, and communication.

Awards and Honors

Although specific awards and honors have not been listed in the current nomination, Yijun Xiao’s publication record and involvement in high-impact journals suggest implicit recognition of his work. His article in Advanced Science—a prestigious international journal—indicates that his research meets the highest standards of innovation and scholarly contribution. Furthermore, the fact that he serves in editorial capacities for journals such as IEEE Transactions on Nanobioscience and IEEE Access is a significant mark of honor, especially for a Ph.D. candidate. These roles are typically reserved for researchers with demonstrated subject-matter expertise and strong academic judgment. Xiao has also been selected to present at esteemed international conferences like the IEEE Smart World Congress and the International Conference on Industrial Artificial Intelligence, which reflects peer recognition of the novelty and relevance of his work. His patent filings further emphasize the originality of his ideas and their potential for real-world application. While not formal awards, these accomplishments reflect an ongoing stream of recognition from the global academic and research community. As his career progresses, he is poised to receive formal accolades and fellowships that match the significance of his contributions.

Conclusion

Yijun Xiao represents the ideal profile of a next-generation researcher whose work is at the forefront of interdisciplinary science. His commitment to advancing DNA computing and molecular neural networks is both ambitious and impactful, addressing fundamental challenges in computational complexity using innovative biological models. Despite being in the early phase of his academic career, his productivity, publication quality, and international engagement far exceed typical expectations for a doctoral candidate. His research not only contributes theoretical value but also opens doors to practical applications in non-silicon-based computing and synthetic biology. With four patents and six SCI-indexed journal publications, he has already laid a strong foundation for an influential academic and research career. His future potential is further enhanced by his editorial experience, collaborative nature, and ability to lead projects that intersect multiple disciplines. Moving forward, expanding his work into industrial partnerships and broader scientific collaborations will further solidify his standing. Overall, Yijun Xiao is not only suitable for the Best Researcher Award but is a compelling candidate who exemplifies excellence, innovation, and future leadership in cutting-edge research domains.

Publications Top Notes

  1. Title: Programmable DNA‐Based Molecular Neural Network Biocomputing Circuits for Solving Partial Differential Equations
    Authors: Yijun Xiao, Alfonso Rodríguez‐Patón, Jianmin Wang, Pan Zheng, Tongmao Ma, Tao Song
    Year: 2025
    Journal: Advanced Science
  2. Title: Cascade PID Control Systems Based on DNA Strand Displacement With Application in Polarization of Tumor-Associated Macrophages
    Authors: Hui Xue, Hui Lv, Yijun Xiao, Xing’An Wang
    Year: 2023
    Journal: IEEE Access
  3. Title: Implementation of an Ultrasensitive Biomolecular Controller for Enzymatic Reaction Processes With Delay Using DNA Strand Displacement
    Authors: Yijun Xiao, Hui Lv, Xing’An Wang
    Year: 2023
    Journal: IEEE Transactions on NanoBioscience
  4. Title: Performance Verification of Smith Predictor Control Using IMC Scheme via Chemical Reaction Networks and DNA Strand Displacement Reaction
    Authors: Jingwang Yao, Hui Lv, Yijun Xiao
    Year: 2023
    Conference: 2023 IEEE Smart World Congress (SWC)
  5. Title: Synthetic Biology and Control Theory: Designing Synthetic Biomolecular Controllers by Exploiting Dynamic Covalent Modification Cycle with Positive Autoregulation Properties
    Authors: Yijun Xiao, Hui Lv, Xing’an Wang
    Year: 2023
    Journal: Applied Sciences
  6. Title: Implementing a modified Smith predictor using chemical reaction networks and its application to protein translation
    Authors: Yijun Xiao, Hui Lv, Xing’an Wang
    Year: 2022
    Conference: 2022 4th International Conference on Industrial Artificial Intelligence (IAI)

Zhen Ma | Surgical Oncology | Best Researcher Award

Posted on by Shen Awards

Dr. Zhen Ma | Surgical Oncology | Best Researcher Award

Chief Resident from The Second Hospital of Lanzhou University, China

Dr. Zhen Ma is a skilled surgical oncologist specializing in gastrointestinal malignancies with advanced training in minimally invasive and robotic surgical procedures. His professional practice centers at The Second Hospital of Lanzhou University, a Grade A tertiary institution in China, where he leads surgical interventions in gastric, hepatic, and colorectal cancers. In addition to his clinical responsibilities, Dr. Ma is a dedicated researcher whose work explores resistance mechanisms in gastrointestinal tumors and innovations in surgical technology. He has authored over seven first-author publications in reputable peer-reviewed journals, contributing to the growing body of knowledge in oncology and surgical techniques. Furthermore, Dr. Ma has played key roles in more than 16 phase I–III clinical trials related to advanced solid tumors, demonstrating his expertise in clinical trial management and cancer therapeutics. His ability to integrate clinical expertise with research insights positions him as an emerging leader in surgical oncology. He is fluent in medical English, possesses extensive training in research methodologies, and actively contributes to the evolution of cancer care in China. With ongoing involvement in national research projects, clinical innovations, and the development of surgical devices, Dr. Ma exemplifies the qualities of a modern clinician-scientist committed to translational medicine and precision oncology.

Professional Profile

Education

Dr. Zhen Ma has pursued a rigorous academic pathway that reflects his dedication to excellence in medicine and oncology. He earned his Bachelor of Medicine (B.M.) in Clinical Medicine from Wuhan University (2006–2011), one of China’s top medical institutions. Following this, he completed a Master of Medicine (M.M.) in Surgery at the prestigious Zhejiang University from 2012 to 2015, where he deepened his surgical skills and began his early clinical work. His academic journey culminated with a Ph.D. in Oncology, with a focus on digestive tract tumors, from Lanzhou University (2019–2024), an institution known for its cancer research in northwest China. His doctoral research has concentrated on chemoresistance mechanisms and autophagy-related genes in gastric cancer. Each academic phase has equipped Dr. Ma with a solid foundation in clinical medicine, advanced surgical practice, and scientific research. His education reflects a balance between practical surgical expertise and a sophisticated understanding of molecular oncology. By pursuing advanced degrees from diverse top-tier universities, Dr. Ma has gained a multidisciplinary academic background that enhances his ability to approach oncological challenges from both a clinical and research perspective.

Professional Experience

Dr. Zhen Ma has cultivated a comprehensive professional background as a practicing surgical oncologist and academic researcher. He began his medical career as a surgeon at The Second Hospital of Lanzhou University in 2015, where he initially focused on thyroid oncology using minimally invasive approaches. In 2018, he advanced to the position of attending surgeon in the Department of Surgical Oncology, specializing in the surgical management of gastric, colorectal, hepatic, and biliary tract cancers. He is proficient in Enhanced Recovery After Surgery (ERAS) protocols, which have significantly improved patient outcomes, reducing complications by 30%. He also pioneered the clinical use of indocyanine green (ICG) fluorescence navigation for bilioenteric anastomosis, lowering leakage rates to below 2%. In addition to his surgical work, Dr. Ma has inserted and maintained over 100 venous infusion ports to facilitate chemotherapy for cancer patients. His professional practice is marked by a blend of innovative surgical intervention, commitment to patient safety, and continuous adoption of cutting-edge techniques. He has also served as the lead surgeon in device innovation trials and co-investigator on national-level oncology research projects, illustrating his seamless integration of clinical excellence with medical innovation and translational research.

Research Interests

Dr. Zhen Ma’s research interests are rooted in gastrointestinal oncology, with a specific focus on molecular mechanisms of chemoresistance, autophagy-related gene signatures, and minimally invasive surgical innovations. His doctoral work investigates how autophagy influences prognosis and treatment outcomes in gastric and hepatocellular carcinomas. Dr. Ma is deeply engaged in translational research that bridges molecular biology with clinical application, exemplified by his participation in studies exploring gene markers for drug resistance and survival prediction. Additionally, he has developed an interest in robotic and laparoscopic techniques as part of enhancing surgical precision and patient recovery. His participation in numerous clinical trials, including phase III studies on SOX-based chemotherapy regimens and targeted immunotherapy agents such as camrelizumab, reflects his dedication to integrating novel systemic therapies into surgical oncology. Another critical area of his research includes medical device innovation, where he led clinical trials on laparoscopic endoscopic systems for splenectomy and thyroid surgery. Overall, Dr. Ma’s research demonstrates a comprehensive approach to cancer care that includes genetics, clinical treatment optimization, and real-time surgical navigation—all aimed at improving survival rates and quality of life for gastrointestinal cancer patients.

Research Skills

Dr. Zhen Ma possesses a strong portfolio of technical and research skills that support his role as a clinician-scientist. Technically, he is adept at laparoscopic and robotic surgical techniques, ICG fluorescence imaging, thyroidectomy, and venous port placement, which are core to his surgical oncology practice. On the research side, Dr. Ma is proficient in clinical trial design and execution, supported by his Good Clinical Practice (GCP) certification. He is skilled in molecular biology techniques that include autophagy-related gene analysis and immunological assessments—crucial for understanding tumor behavior and therapy resistance. In data analysis, Dr. Ma uses software such as SPSS and R for biostatistical modeling, survival analysis, and interpretation of clinical data. He also has experience drafting case reports, literature reviews, and scientific papers for international journals. His language proficiency in both Mandarin and medical English allows him to collaborate across institutions and contribute to global research discourse. These skills make him well-equipped to design impactful studies, evaluate complex datasets, and implement innovative surgical and medical interventions with academic rigor and ethical integrity.

Awards and Honors

Although specific national or international awards are not listed in the available information, Dr. Zhen Ma’s career achievements reflect honors of clinical innovation and research leadership. Notably, he is the lead inventor of two patents: one for an abdominal belt to prevent drainage tube compression, and another for a nutrition tube unblocking device, both granted in 2020. These inventions show his ability to translate bedside challenges into tangible medical devices, which is a hallmark of applied medical innovation. Additionally, his successful participation as a Principal Investigator (PI) and Sub-Investigator (Sub-I) in high-level multicenter clinical trials reflects recognition from the national research community and pharmaceutical collaborators. His role in government-funded research projects, such as the National Health Commission GI Tumor Lab and the NSFC dual liver transplant immunology study, signifies peer trust and institutional acknowledgment of his research capacity. Furthermore, his appointment as an attending surgeon at a Grade A tertiary hospital at a relatively early stage in his career highlights the institutional confidence in his clinical and academic capabilities. These achievements position him as an award-worthy researcher contributing meaningfully to clinical practice and surgical science.

Conclusion

Dr. Zhen Ma is a dedicated and forward-thinking surgical oncologist who integrates clinical excellence with research-driven innovation. With an academic background from top Chinese universities and clinical experience at a leading tertiary care hospital, he has built a robust foundation in both patient care and medical science. His research in autophagy and chemoresistance contributes valuable insights to gastrointestinal cancer management, while his involvement in clinical trials bridges cutting-edge therapies with real-world application. His technical innovations, including ICG-guided surgery and patented medical devices, further demonstrate his commitment to enhancing patient outcomes through practical solutions. Dr. Ma’s work exemplifies the principles of translational medicine—moving from bench to bedside with measurable impact. Though early in his academic career, he has already achieved notable success in publications, research leadership, and surgical outcomes. With potential for expanded international collaboration and high-impact research publication, Dr. Ma is well-positioned to continue advancing the field of surgical oncology. As such, he represents an ideal candidate for the Best Researcher Award, honoring both his past accomplishments and his promising future contributions to medicine and clinical science.

Publications Top Notes

1. Comparative investigation of early-onset gastric cancer
Authors: Ma Z, Liu X, Paul ME, Chen M, Zheng P, Chen H
Year: 2021

2. Real-time indocyanine green fluorescence technique reduces anastomotic leakage in bilioenteric anastomosis: A case report and literature review
Authors: Ma Z, Deng J, Ma B, Chen H
Year: 2023

3. Identification and verification of a prognostic autophagy-related gene signature in hepatocellular carcinoma
Authors: Ma Z, Chen M, Liu X, Cui H
Year: 2024

4. Robotic Versus Total Laparoscopic Splenectomy With Pericardial Devascularisation for Portal Hypertension: A Retrospective Cohort Study
Authors: Ma Z, Cui H, Gaoi L, Ma B, He P, Yu Y, Wang Y, Ma Y, Chen H
Year: 2025

5. Prevention of ERCP complications
Authors: Ma Z, Li X, et al.
Year: 2019

6. Liver transplantation in primary sclerosing cholangitis
Authors: Ma Z, Tao P, et al.
Year: 2018